UPF0421 protein BA_2743/GBAA_2743/BAS2557 is a protein identified in Bacillus anthracis, the gram-positive, spore-forming bacterium responsible for anthrax disease. The designation "UPF" (Uncharacterized Protein Family) indicates that this protein belongs to a family whose precise biological functions have not been fully elucidated . The identifiers BA_2743, GBAA_2743, and BAS2557 represent the gene locus designations in different B. anthracis strain annotations, referring to essentially the same protein across these strains . This protein has been assigned the UniProt identifier Q81PQ8, providing a standardized reference point in protein databases .
The protein is part of a conserved family found across multiple bacterial species, as evidenced by the existence of homologous proteins such as UPF0421 protein SA1705 in Staphylococcus aureus . This conservation across different bacterial species suggests that the protein may serve fundamental functions in bacterial physiology. While direct functional characterization remains limited, research into its recombinant forms has progressed significantly, offering insights into its structural and biochemical properties.
Based on sequence analysis and comparison with similar proteins, UPF0421 protein BA_2743/GBAA_2743/BAS2557 likely contains multiple transmembrane domains. The N-terminal region contains sequences characteristic of signal peptides, suggesting the protein may be exported or membrane-anchored . While definitive three-dimensional structural data is not yet available for this specific protein, researchers have made progress in determining structures of other B. anthracis proteins, establishing methodologies that could be applied to UPF0421 .
The recombinant UPF0421 protein BA_2743/GBAA_2743/BAS2557 can be expressed using several different host systems, each with distinct advantages depending on research requirements. Table 1 summarizes the key expression systems and their characteristics:
| Expression System | Advantages | Applications | Production Time |
|---|---|---|---|
| Escherichia coli | High yields, cost-effective, scalable | Structural studies, antibody production | Short (days) |
| Yeast | Good yields, some post-translational modifications | Functional studies | Medium (days to weeks) |
| Insect cells | Post-translational modifications, proper folding | Activity assays, structural studies | Medium to long (weeks) |
| Mammalian cells | Extensive post-translational modifications, native-like folding | Activity studies, interaction studies | Long (weeks) |
E. coli and yeast expression systems typically offer the best yields and shorter turnaround times, making them preferred choices for large-scale production and initial characterization studies . For applications requiring post-translational modifications necessary for correct protein folding or retention of specific activities, insect cells with baculovirus or mammalian expression systems may be more appropriate .
Purification of recombinantly expressed UPF0421 protein typically employs affinity chromatography, often facilitated by the addition of affinity tags such as histidine tags . The recombinant protein can be produced with high purity (>90% as determined by SDS-PAGE) through optimized purification protocols . For specific applications, the protein can be produced in different forms, including lyophilized powder that can be reconstituted as needed .
While the specific function of UPF0421 protein BA_2743/GBAA_2743/BAS2557 remains to be fully characterized, several lines of evidence suggest potential roles in B. anthracis physiology:
The amino acid sequence of UPF0421 contains multiple hydrophobic regions consistent with transmembrane domains, suggesting a role in membrane structure or transport processes . Similar bacterial transmembrane proteins often function in nutrient uptake, signal transduction, or export of cellular components . The protein may contribute to B. anthracis membrane integrity or permeability, which are critical factors in bacterial survival and adaptation to different environments.
To understand the potential significance of UPF0421 protein, it's important to consider the broader context of B. anthracis biology. The bacterium possesses a complex cell envelope architecture, including a thick peptidoglycan layer, secondary cell wall polysaccharides, S-layer proteins, and in virulent strains, a poly-γ-D-glutamic acid capsule .
Recent research has revealed that non-virulence-associated components of B. anthracis can significantly impact bacterial physiology and potentially influence pathogenesis indirectly. For example, studies have shown that certain spore components, such as the exosporium sugar anthrose, can affect vegetative B. anthracis gene regulation in both cis and trans configurations . While UPF0421 has not been directly implicated in these processes, its conservation across different bacterial species suggests it may serve important cellular functions.
Recombinant UPF0421 protein BA_2743/GBAA_2743/BAS2557 serves as a valuable tool for various research applications:
The availability of high-purity recombinant protein enables the development of antibodies against UPF0421, which can be used for detection, localization, and functional studies . ELISA kits utilizing this recombinant protein allow for sensitive and specific detection applications, potentially contributing to diagnostic or research methodologies .
The recombinant protein can be employed in interaction studies to identify binding partners and potential functional networks. Techniques such as affinity purification coupled with mass spectrometry, yeast two-hybrid screening, or surface plasmon resonance could reveal proteins or other molecules that interact with UPF0421, providing clues about its cellular roles.
Research into B. anthracis proteins, including UPF0421, contributes to the broader understanding of anthrax biology and potential therapeutic approaches:
Anthrax primarily affects humans and ungulates, with three main forms of infection: cutaneous, gastrointestinal, and pulmonary (inhalational). While the primary virulence factors of B. anthracis are its tripartite toxin and poly-γ-D-glutamic acid capsule , auxiliary proteins like UPF0421 may contribute to bacterial fitness, survival, or adaptation during infection.
Understanding the structure and function of B. anthracis proteins provides potential targets for novel therapeutic approaches. Cell envelope components, including membrane proteins, represent accessible targets for antimicrobial development . While UPF0421 has not been directly implicated as a virulence factor, its potential role in bacterial physiology makes it a candidate for basic research that could inform future therapeutic strategies.
KEGG: ban:BA_2743
STRING: 260799.BAS2557
The recombinant UPF0421 protein BA_2743/GBAA_2743/BAS2557 can be expressed in multiple host systems, each with distinct advantages:
| Expression System | Advantages | Considerations |
|---|---|---|
| E. coli | Best yields, shorter turnaround times, cost-effective | Limited post-translational modifications |
| Yeast | Good yields, some eukaryotic modifications, shorter turnaround | More complex media requirements |
| Insect cells/baculovirus | Many post-translational modifications, better folding for complex proteins | Lower yields, longer production time |
| Mammalian cells | Most native-like post-translational modifications, best for retaining activity | Lowest yields, highest cost, longest production time |
For optimal stability and activity retention of recombinant UPF0421 protein BA_2743, follow these research-validated storage and handling protocols:
Short-term storage: Store working aliquots at 4°C for up to one week
Long-term storage: Store at -20°C, or preferably at -80°C for extended periods
Buffer composition: Typically supplied in Tris-based buffer with 50% glycerol or Tris/PBS-based buffer with 6% trehalose, pH 8.0
Reconstitution: For lyophilized protein, briefly centrifuge the vial before opening, then reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Aliquoting: Add 5-50% glycerol (final concentration) and prepare multiple small-volume aliquots to avoid repeated freeze-thaw cycles
Important note: Repeated freezing and thawing significantly reduces protein activity and should be avoided
Purity assessment for recombinant UPF0421 protein BA_2743 typically employs multiple complementary techniques:
Primary method: SDS-PAGE with Coomassie or silver staining, aiming for purity greater than 90% as the standard quality threshold . This method separates proteins by molecular weight, allowing visualization of the target protein band at approximately 40-42 kDa and detection of potential contaminants.
Western blotting using anti-His antibodies (when His-tagged)
Size exclusion chromatography (SEC) to assess monodispersity and aggregation
Mass spectrometry to confirm exact molecular weight and sequence coverage
For research applications requiring extremely high purity, additional techniques may include:
Reverse-phase HPLC
Isoelectric focusing
Native PAGE to assess conformational homogeneity
For maximum yield and solubility of UPF0421 protein BA_2743 in E. coli expression systems, consider implementing these research-backed optimization strategies:
BL21(DE3) derivatives often provide highest yields for potentially toxic membrane-associated proteins
pET vectors with T7 promoters allow tight regulation of expression
Consider C41/C42 strains specifically designed for membrane proteins
Test induction at different OD600 values (0.6-1.0)
Compare IPTG concentrations (0.1-1.0 mM)
Evaluate lower temperatures (16-25°C) during induction to improve folding
Extended expression periods (16-24 hours) at lower temperatures
Co-expression with molecular chaperones (GroEL/GroES, DnaK/DnaJ)
Fusion partners (MBP, SUMO, or TRX) can significantly increase solubility
Addition of compatible solutes (5-10% glycerol, 0.5-1M sorbitol) to expression media
This methodological approach addresses the common challenge that UPF0421 family proteins, having potential membrane-spanning domains, may exhibit limited solubility when expressed in standard conditions .
Given the predicted membrane-associated nature of UPF0421 protein BA_2743, a systematic experimental approach to characterize its membrane interaction properties includes:
Fractionate E. coli cells expressing the protein into cytoplasmic, peripheral membrane, and integral membrane fractions
Use differential detergent treatments (mild detergents like digitonin followed by stronger ones like Triton X-100)
Analyze distribution by Western blotting to determine membrane association strength
Protease protection assays with inside-out and right-side-out membrane vesicles
Site-directed fluorescence labeling at predicted loop regions
Cysteine scanning mutagenesis combined with accessibility studies
Circular dichroism (CD) spectroscopy in membrane-mimetic environments
Reconstitution in liposomes of defined composition followed by flotation assays
Microscale thermophoresis to measure lipid binding affinities
The amino acid sequence analysis reveals multiple hydrophobic regions typical of membrane-spanning domains, particularly in the N-terminal half of the protein, supporting its predicted membrane association .
Determining the function of UPF0421 protein BA_2743 requires an integrated, multi-omics approach:
Analyze gene neighborhood conservation across Bacillus species
Identify co-evolved gene clusters through phylogenetic profiling
Compare sequence similarity with characterized UPF0421 proteins from related organisms like Bacillus cereus (BC_2748) and Bacillus thuringiensis (BT9727_2513)
Bacterial two-hybrid screening to identify interacting partners
Co-immunoprecipitation followed by mass spectrometry
Proximity-dependent biotin labeling (BioID) in heterologous systems
Gene knockout/knockdown in Bacillus species followed by comprehensive phenotyping
Heterologous expression in model organisms to observe gain-of-function phenotypes
Transcriptomic analysis of mutant strains under various stress conditions
X-ray crystallography or cryo-EM to identify potential binding pockets
Molecular docking simulations with metabolites from relevant biochemical pathways
In silico structural comparisons with proteins of known function
This multi-faceted approach has proven effective for functional annotation of previously uncharacterized proteins across various bacterial species.
To comprehensively map the interactome of UPF0421 protein BA_2743, researchers should employ complementary techniques that address both stable and transient interactions:
Surface plasmon resonance (SPR) for real-time binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Biolayer interferometry (BLI) to measure association/dissociation rates
Bacterial two-hybrid or three-hybrid systems
Split-GFP complementation assays
FRET/BRET-based interaction studies in live bacterial cells
Protein microarrays using purified Bacillus anthracis proteome
Tandem affinity purification followed by mass spectrometry (TAP-MS)
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map interaction interfaces
Co-immunoprecipitation with specific antibodies
Pull-down assays using His-tagged recombinant protein
Size exclusion chromatography with multi-angle light scattering (SEC-MALS)
The GSK2801 chemoproteomic competition binding assay approach described in research paper represents a model methodology that could be adapted for UPF0421 protein interaction studies, using appropriate modifications specific to bacterial protein research.
Comparative analysis of UPF0421 proteins across Bacillus species reveals important structural and potential functional insights:
| Species | Protein Identifier | Length (aa) | Sequence Identity to BA_2743 | Key Structural Features |
|---|---|---|---|---|
| B. anthracis | BA_2743/GBAA_2743/BAS2557 | 355 | 100% (reference) | Multiple transmembrane regions, C-terminal cytoplasmic domain |
| B. cereus | BC_2748 | 351 | ~98% | Nearly identical topology, conservative substitutions |
| B. thuringiensis | BT9727_2513 | 358 | ~95% | Additional short insert in C-terminal region |
| B. subtilis | YgaE | 349 | ~70% | More divergent sequence, conserved membrane topology |
High conservation (>95%) among pathogenic Bacillus species suggests potential role in virulence or survival
Conserved membrane topology implies similar subcellular localization and general function
Differences in C-terminal regions may reflect species-specific protein interactions
Structural conservation:
The computed structure model for BT9727_2513 from B. thuringiensis shows a predominantly alpha-helical architecture with high confidence predictions (pLDDT >90) in the core regions, which likely extends to the highly similar BA_2743 protein .
This comparative approach provides valuable context for functional hypotheses and could guide mutational studies targeting species-specific regions.
Crystallizing potential membrane proteins like UPF0421 BA_2743 presents significant challenges that require specialized techniques:
Solubilize the purified protein in a panel of detergents ranging from mild (DDM, LMNG) to harsh (OG, LDAO)
Assess protein stability and monodispersity by size exclusion chromatography in each detergent
Perform thermal stability assays (DSF/nanoDSF) to identify conditions that maximize protein stability
Proceed with crystallization trials using detergents that yield stable, monodispersic protein
Reconstitute protein in monoolein or other suitable lipid matrices
Set up in meso crystallization trials with various precipitants
Monitor crystal formation using cross-polarized light microscopy
Harvest crystals directly from LCP for X-ray diffraction
Nanodiscs with defined lipid composition
Amphipols (A8-35 or PMAL-C8)
Styrene maleic acid lipid particles (SMALPs)
Peptide-based detergents (peptergents)
Truncation of flexible domains while retaining core structure
Fusion with crystallization chaperones (T4 lysozyme, BRIL)
Surface entropy reduction through strategic mutation of surface residues
Antibody fragment (Fab/nanobody) co-crystallization to provide crystal contacts
The methodological combination of these approaches has proven successful for crystallizing challenging membrane proteins and could be adapted specifically for UPF0421 BA_2743.